Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

NCT03473730 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Bladder Urothelial Carcinoma
Clear Cell Renal Cell Carcinoma
Malignant Urinary System Neoplasm
Metastatic Kidney Carcinoma
Stage IV Renal Cell Cancer AJCC V8

Interventions

PROCEDURE: Biopsy
BIOLOGICAL: Daratumumab
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Metastasectomy
PROCEDURE: Nephrectomy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]